FDA has sent a warning letter to a Portland-area compounding pharmacy listing six violations, including sterile practices.
The letter was sent to Oregon Compounding Centers, Inc., in Wilsonville, Ore., which does business as Creative Compounds. Last October, Creative Compounds voluntarily recalled certain unexpired human and veterinary sterile products. At the time, company officials said they had not received any reports of product contamination or adverse events, but took the step as a precautionary measure.
No comments:
Post a Comment